超声与数字乳腺断层合成在局灶性乳腺症状女性中的应用:Breast US Trial (BUST) 结果
该前瞻性研究纳入1961名30岁以上有局灶性乳腺症状的女性,先进行靶向超声(必要时活检),随后进行数字乳腺断层合成(DBT)。以1年随访或组织病理为参考标准,单独超声诊断准确,敏感度98.5%,特异度90.8%;DBT仅额外检出3个症状部位恶性肿瘤和0.41%的偶发恶性病变。结论提示靶向超声可作为独立影像模态评估局灶性乳腺症状,DBT的补充价值有限。
要点
- 靶向超声单独评估局灶性乳腺症状敏感度98.5%、特异度90.8%,可作为初始影像模态。
- DBT在超声阴性时仅额外检出3个症状部位恶性肿瘤,补充价值低。
- DBT检出的偶发恶性病变率为0.41%,与筛查乳腺X线摄影的癌症检出率相当。
英文原文(摘要)· 点击展开
Background Digital breast tomosynthesis (DBT) followed by targeted US is commonly performed to evaluate women with localized breast complaints. However, the added value of DBT in addition to targeted US is unknown. Omitting DBT may be cost-effective and improve patient comfort but may miss potential breast cancer. Purpose To assess whether an imaging protocol consisting of targeted US alone may be feasible for the diagnostic work-up of women with localized symptoms and to assess the supplemental value of DBT in this reversed setting. Materials and Methods This prospective study enrolled consecutive women aged 30 years or older with focal breast complaints in three hospitals in the Netherlands between September 2017 and June 2019. In all participants, first, targeted US was evaluated, and if needed, biopsy was performed, followed by DBT. The primary outcome was the frequency of breast cancer detected with DBT when US was negative. Secondary outcomes were frequency of cancer detected with DBT elsewhere in the breast and combined overall sensitivity of US plus DBT. The reference standard was 1 year follow-up or histopathologic examination. Results There were 1961 women (mean age ± SD, 47 years ± 12) enrolled. Based on initial US alone, 1587 participants (81%) had normal or benign findings and 1759 (90%) had a definitive accurate diagnosis. In total, 204 breast cancers were detected during initial work-up. The frequency of malignancy was 10% (192 of 1961 participants) with US (US sensitivity, 98.5% [95% CI: 96, 100]; US specificity, 90.8% [95% CI: 89, 92]). DBT depicted three unobserved malignant lesions at the complaint site and 0.41% (eight of 1961 participants) of incidental malignant findings in participants without symptomatic cancer. Conclusion Compared with combined US and DBT, US was accurate as a stand-alone breast imaging modality in the assessment of focal breast complaints. The rate of cancer detection of cancers elsewhere in the breast with DBT is comparable to cancer detection rate of screening mammography. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Newell in this issue.
引用
- Appelman, Siebers, Appelman, et al. US and Digital Breast Tomosynthesis in Women with Focal Breast Complaints: Results of the Breast US Trial (BUST). Radiology. 2023. PMID: 37014237. doi:10.1148/radiol.220361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。